investment analyst coverage
Barclays Initiates Coverage of Agilent
Analysts gave Agilent an Equal Weight rating on expectations the company is positioned for long-term growth, but said that investors may find a better price to take action on the stock.
UBS Initiates Coverage of Exact Sciences, Natera, Guardant Health
The investment bank gave Natera and Guardant Health a Buy rating and Exact Sciences a Neutral rating.
Craig-Hallum Initiates Coverage of Guardant Health With Buy Rating
The investment bank focused mainly on its expectations for Guardant's colorectal cancer screening assay, but also argued its overall business is poised for significant growth.
Craig-Hallum Downgrades Exact Sciences to Hold, Lowers Price Target to $35
Analysts for the bank cited expected competition from Guardant Health's blood-based colorectal cancer test, as well as market challenges for Exact's Cologuard.
UBS Initiates Coverage on QuidelOrtho, Waters, PerkinElmer, Hologic, Agilent Technologies
The investment bank also released an updated rating for Danaher as it expanded its coverage of the life science tools and diagnostic market.